ConductScience.org, home

Paper · 7686841

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12409168Neuropeptide regulation of the expression of immediate hypersensitivity.J Immunol1985https://conductscience.org/library/papers/2409168PubMed
2349569Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences on gastric secretion.Proc Soc Exp Biol Med1978https://conductscience.org/library/papers/349569PubMed
31672856The effect of vasoactive intestinal polypeptide on gastric acid secretion is predominantly mediated by somatostatin.Gastroenterology1991https://conductscience.org/library/papers/1672856PubMed
42409146Mast cell heterogeneity: effects of neuroenteric peptides on histamine release.J Immunol1985https://conductscience.org/library/papers/2409146PubMed
56806139Effect of vasoactive intestinal peptide on gastric secretion in the cat.Gastroenterology1982https://conductscience.org/library/papers/6806139PubMed
62464382Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.Br J Pharmacol1988https://conductscience.org/library/papers/2464382PubMed
72414197Gastroduodenal mucosal hormone content in duodenal ulcer disease.Hepatogastroenterology1985https://conductscience.org/library/papers/2414197PubMed
85069712Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.Eur J Biochem1972https://conductscience.org/library/papers/5069712PubMed
92897796Modulatory effect of glucose on VIP-induced gastric somatostatin release.Am J Physiol1988https://conductscience.org/library/papers/2897796PubMed
106958342Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.Br J Pharmacol1982https://conductscience.org/library/papers/6958342PubMed
1181468Release of vasoactive intestinal polypeptide in mast cells by histamine liberators.Nature1978https://conductscience.org/library/papers/81468PubMed
122456788Differential actions of phosphodiesterase inhibitors on secretin- and vasoactive intestinal peptide-induced increases in chief cell cAMP.Biochim Biophys Acta1988https://conductscience.org/library/papers/2456788PubMed
133871087Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat.Gastroenterology1985https://conductscience.org/library/papers/3871087PubMed
143335281Studies on the mechanism of ethanol-induced gastric damage in rats.Gastroenterology1988https://conductscience.org/library/papers/3335281PubMed
156194695Potentiation of pepsinogen secretion from dispersed glands from rat stomach.Am J Physiol1983https://conductscience.org/library/papers/6194695PubMed
166675186The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man.Scand J Gastroenterol1983https://conductscience.org/library/papers/6675186PubMed
171707383Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.Gastroenterology1991https://conductscience.org/library/papers/1707383PubMed
186103859Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.Gastroenterology1980https://conductscience.org/library/papers/6103859PubMed
192421587Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.Am J Physiol1986https://conductscience.org/library/papers/2421587PubMed
202422264Substance P: binding properties and studies on cellular responses in guinea pig macrophages.J Immunol1986https://conductscience.org/library/papers/2422264PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/7686841/references